Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083456 · ClinicalTrials.gov registry record · Phase 2
Dysvascular Amputation Self-Management of Health
A Phase 2 study of Diabetes Mellitus and Amputation, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04083456 is a Phase 2 study of Diabetes Mellitus and Amputation that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04083456, a Phase 2 study of Diabetes Mellitus and Amputation, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.
Conditions Studied
Interventions
- OTHER Attention Control
- BEHAVIORAL Walking Biobehavioral Intervention
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2025-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04083456
The ClinicalTrials.gov registry entry for NCT04083456 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT04083456 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04083456 about?
NCT04083456 is a clinical study titled "Dysvascular Amputation Self-Management of Health". The purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.
What is the current status of trial NCT04083456?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2019-11-01. Estimated completion is 2025-05-31.
What conditions does trial NCT04083456 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Amputation, Peripheral Artery Disease.
What interventions are being tested in trial NCT04083456?
The interventions under investigation include: Attention Control (OTHER), Walking Biobehavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04083456?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04083456 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
RECRUITING · Phase 2
-
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus
RECRUITING · Phase 2
-
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
RECRUITING · Phase 2
-
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
RECRUITING · Phase 2
-
Sleep, Diabetic Retinopathy and Melatonin
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.